参考文献/References:
[1]Mogensen CE,Christensen CK,Vittinghus E.The stages in diabetic renal disease:with emphasis on the stage of incipient diabetic nephropathy[J].Diabetes,1983,32(Supplement 2):64-78.
[2]Cho N H,David W,Guariguata L.IDF Diabetes Atlas Sixth edition[J].International Diabetes Federation,2014.
[3]Kawanami D,Matoba K,Utsunomiya K.Signaling pathways in diabetic nephropathy[J].Histol Histopathol,2016,31(10):1059-1067.
[4]ElGamal H,Munusamy S.Aldose Reductase as a Drug Target for Treatment of Diabetic Nephropathy:Promises and Challenges[J].Protein Pept Lett,2017,24(1):71-77.
[5]Lewko B,Latawiec E,Maryn A,et al.Osmolarity and glucose differentially regulate aldose reductase activity in cultured mouse podocytes[J].Exp Diabetes Res,2011:278963.
[6]Jiang W,Li Z,Zhao W,et al.Breviscapine attenuatted contrast medium-induced nephropathy via PKC Akt MAPK signalling in diabetic mice[J].Am J Transl Res,2016,8(2):329-341.
[7]Moradi M,Rahimi Z,Amiri S,et al.AT1R A1166C variants in patients with type 2 diabetes mellitus and diabetic nephropathy[J].J Nephropathol,2015,4(3):69-76.
[8]Zain M,Awan FR.Renin Angiotensin Aldosterone System(RAAS):its biology and drug targets for treating diabetic nephropathy[J].Pak J Pharm Sci,2014,27(5):1379-1391.
[9]Toyama T,Shimizu M,Furuichi K,et al.Treatment and impact of dyslipidemia in diabetic nephropathy[J].Clin Exp Nephrol,2014,18(2):201-205.
[10]Chen G,Wang T,Uttarwar L,et al.SREBP-1 is a novel mediator of TGFβ1 signaling in mesangial cells[J].J Mol Cell Biol,2014,6(6):516-530.
[11]Xie S,Lu K,Zhang Y,et al.Effects of Jiangya Xiaoke prescription on TGF-β1 in diabetic nephropathy rats with hypertension and its mechanisms[J].Int J Clin Exp Med,2015,8(4):5129-5136.
[12]Van Krieken R,Chen G,Gao B,et al.Sterol Regulatory Element Binding Protein(SREBP)-1 is a novel regulator of the Transforming Growth Factor(TGF)-β receptor I(TβRI) through exosomal secretion[J].Cell Signal,2017,29(5):158-167.
[13]Wen D,Huang X,Zhang M,et al.Resveratrol attenuates diabetic nephropathy via modulating angiogenesis[J].PLoS One,2013,8(12):e82336.
[14]Patel L,Thaker A.The effects of adenosine A2B receptor inhibition on VEGF and nitric oxide axis-mediated renal function in diabetic nephropathy[J].Ren Fail,2014,36(6):916-924.
[15]Sun L,Kanwar YS.Relevance of TNF-α in the context of other inflammatory cytokines in the progression of diabetic nephropathy[J].Kidney Int,2015,88(4):662-665.
[16]Guo Y,Song Z,Zhou M,et al.Infiltrating macrophages in diabetic nephropathy promote podocytes apoptosis via TNF-α-ROS-p38MAPK pathway[J].Oncotarget,2017,8(32):53276-53287.
[17]Bondeva T,Wolf G.Reactive oxygen species in diabetic nephropathy:friend or foe[J].Nephrol Dial Transplant,2014,29(11):1998-2003.
[18]Yuan F,Liu YH,Liu FY,et al.Intraperitoneal administration of the globular adiponectin gene ameliorates diabetic nephropathy in Wistar rats[J].Mol Med Rep,2014,9(6):2293-2300.
[19]Zhu K,Kakehi T,Matsumoto M,et al.NADPH oxidase NOX1 is involved in activation of protein kinase C and premature senescence in early stage diabetic kidney[J].Free Radic Biol Med,2015,83(2):21-30.
[20]Tang ZH,Zeng F,Zhang XZ.Human genetics of diabetics nephropathy[J].Ren Fail,2015,37(3):363-371.
[21]McKnight AJ,Duffy S,Maxwell AP.Genetics of diabetic nephropathy:a long road of discovery[J].Curr Diab Rep,2015,15(7):41.
相似文献/References:
[1]刘 璐,秦新月.阿尔茨海默病患者血尿酸水平变化的研究[J].医学信息,2018,31(02):96.[doi:10.3969/j.issn.1006-1959.2018.02.033]
LIU Lu,QIN Xin-yue.Study on the Changes of Serum Uric Acid in Alzheimer 's Disease Patients[J].Journal of Medical Information,2018,31(16):96.[doi:10.3969/j.issn.1006-1959.2018.02.033]
[2]陈淑雯.肾衰宁联合科素亚治疗早期糖尿病肾病的临床观察[J].医学信息,2018,31(05):20.[doi:10.3969/j.issn.1006-1959.2018.05.007]
CHEN Shu-wen.Clinical Observation on Early Diabetic Nephropathy Treated by Shenshuaining Combined with Kosu[J].Journal of Medical Information,2018,31(16):20.[doi:10.3969/j.issn.1006-1959.2018.05.007]
[3]王玉霞.剖宫产术后子宫疤痕妊娠的临床诊治[J].医学信息,2018,31(10):48.[doi:10.3969/j.issn.1006-1959.2018.10.015]
WANG Yu-xia.Clinical Diagnosis and Treatment of Uterine Scar Pregnancy after Cesarean Section[J].Journal of Medical Information,2018,31(16):48.[doi:10.3969/j.issn.1006-1959.2018.10.015]
[4]何丽杰.中西医治疗糖尿病肾病的临床效果分析[J].医学信息,2018,31(10):149.[doi:10.3969/j.issn.1006-1959.2018.10.051]
HE Li-jie.Clinical Effect Analysis of Diabetic Nephropathy Treated by Chinese and Western Medicine[J].Journal of Medical Information,2018,31(16):149.[doi:10.3969/j.issn.1006-1959.2018.10.051]
[5]贺 伟,高 峰.24 h尿微量白蛋白、血清胱抑素C水平与血清肌酐、尿素水平在2型糖尿病肾病早期诊断的意义[J].医学信息,2018,31(11):151.[doi:10.3969/j.issn.1006-1959.2018.11.049]
HE Wei,GAO Feng.The Significance of 24 h Urinary Microalbumin,Serum Cystatin C and Serum Creatinine and Urea Levels in the Early Diagnosis of Type 2 Diabetic Nephropathy[J].Journal of Medical Information,2018,31(16):151.[doi:10.3969/j.issn.1006-1959.2018.11.049]
[6]刘革铭,马洪俊,刘 毅,等.心力衰竭的机制及诊疗的研究[J].医学信息,2022,35(10):91.[doi:10.3969/j.issn.1006-1959.2022.10.022]
LIU Ge-ming,MA Hong-jun,LIU Yi,et al.Mechanism, Diagnosis and Treatment of Heart Failure[J].Journal of Medical Information,2022,35(16):91.[doi:10.3969/j.issn.1006-1959.2022.10.022]
[7]只茂叶.重症急性胰腺炎的发病机制与内镜治疗研究[J].医学信息,2022,35(11):68.[doi:10.3969/j.issn.1006-1959.2022.11.019]
ZHI Mao-ye.The Pathogenesis and Endoscopic Treatment of Severe Acute Pancreatitis[J].Journal of Medical Information,2022,35(16):68.[doi:10.3969/j.issn.1006-1959.2022.11.019]
[8]王煜婷.原发性痛经发病机制及口服药物治疗进展[J].医学信息,2018,31(13):56.[doi:10.3969/j.issn.1006-1959.2018.13.016]
WANG Yu-ting.Research Progress in Pathogenesis and Oral Medication of Primary Dysmenorrhea[J].Journal of Medical Information,2018,31(16):56.[doi:10.3969/j.issn.1006-1959.2018.13.016]
[9]黄秋菊.胱抑素C及脂蛋白α在早期糖尿病肾病诊断中的价值研究[J].医学信息,2018,31(14):57.[doi:10.3969/j.issn.1006-1959.2018.14.018]
HUANG Qiu-ju.The Value of Cystatin C and Lipoprotein α in the Diagnosis of Early Diabetic Nephropathy[J].Journal of Medical Information,2018,31(16):57.[doi:10.3969/j.issn.1006-1959.2018.14.018]
[10]陆新虹,温玉洁,胡 欣,等.α-硫辛酸对2型糖尿病肾病患者
血清内脂素的影响研究[J].医学信息,2018,31(14):60.[doi:10.3969/j.issn.1006-1959.2018.14.019]
LU Xin-hong,WEN Yu-jie,HU Xin,et al.Effect of α-lipoic Acid on Serum Visfatin in Patients with
Type 2 Diabetic Nephropathy[J].Journal of Medical Information,2018,31(16):60.[doi:10.3969/j.issn.1006-1959.2018.14.019]